BioCentury | Jan 19, 2015
Financial News

CytoSorbents completes follow-on

...Shares: 1.3 million Price: $8.25 Shares after offering: 24.5 million Underwriters: Brean Capital; H.C. Wainwright; Merriman...
BioCentury | Jan 5, 2015
Financial News

CytoSorbents amends follow-on

...To be raised: TBD Shares: 1.3 million Price prior: $9.80 Underwriters: Brean Capital; H.C. Wainwright; Merriman...
BioCentury | Dec 15, 2014
Financial News

CytoSorbents amends follow-on

...Up to $12.7 million Shares: 2 million Price prior: $5.88 Underwriters: Brean Capital; H.C. Wainwright; Merriman...
BioCentury | Nov 10, 2014
Financial News

Mast Therapeutics completes follow-on

...Units: 30.9 million Price: $0.48 (unit) Shares after offering: 159.5 million Underwriters: Cowen; Canaccord; Laidlaw; Merriman...
BioCentury | Nov 3, 2014
Financial News

AthernoNova completes follow-on

...$3.1 million Shares: 4 million Price: $0.75 Shares after offering: 8.8 million Underwriters: Aegis Capital; Merriman...
BioCentury | Oct 11, 2014
Company News

Management tracks

...banking group. He was previously the head of the healthcare and investment banking team at Merriman...
BioCentury | Sep 29, 2014
Financial News

AthernoNova amends follow-on

...To be raised: Up to $5.8 million Shares: TBD Price prior: $0.37 Underwriters: Aegis Capital; Merriman...
...shares will be sold with a five-year warrant to purchase a share. AtheroNova also added Merriman...
BioCentury | Nov 22, 2010
Finance

Avanir raises $88M after Nuedexta approval for involuntary laughing, crying

...BlackRock (1.9% at Sept. 30). Underwriters were Jefferies; Canaccord; Wedbush; Summer Street Research Partners; and Merriman...
BioCentury | Nov 22, 2010
Financial News

Avanir completes follow-on

...20 million Price: $4.40 Shares after offering: 114 million Underwriters: Jefferies; Canaccord; Wedbush; Summer Street; Merriman...
BioCentury | Nov 18, 2010
Financial News

Avanir raises $88M following Nuedexta approval

...per share in a follow-on underwritten by Jefferies; Canaccord; Wedbush; Summer Street Research Partners; and Merriman...
Items per page:
1 - 10 of 163
BioCentury | Jan 19, 2015
Financial News

CytoSorbents completes follow-on

...Shares: 1.3 million Price: $8.25 Shares after offering: 24.5 million Underwriters: Brean Capital; H.C. Wainwright; Merriman...
BioCentury | Jan 5, 2015
Financial News

CytoSorbents amends follow-on

...To be raised: TBD Shares: 1.3 million Price prior: $9.80 Underwriters: Brean Capital; H.C. Wainwright; Merriman...
BioCentury | Dec 15, 2014
Financial News

CytoSorbents amends follow-on

...Up to $12.7 million Shares: 2 million Price prior: $5.88 Underwriters: Brean Capital; H.C. Wainwright; Merriman...
BioCentury | Nov 10, 2014
Financial News

Mast Therapeutics completes follow-on

...Units: 30.9 million Price: $0.48 (unit) Shares after offering: 159.5 million Underwriters: Cowen; Canaccord; Laidlaw; Merriman...
BioCentury | Nov 3, 2014
Financial News

AthernoNova completes follow-on

...$3.1 million Shares: 4 million Price: $0.75 Shares after offering: 8.8 million Underwriters: Aegis Capital; Merriman...
BioCentury | Oct 11, 2014
Company News

Management tracks

...banking group. He was previously the head of the healthcare and investment banking team at Merriman...
BioCentury | Sep 29, 2014
Financial News

AthernoNova amends follow-on

...To be raised: Up to $5.8 million Shares: TBD Price prior: $0.37 Underwriters: Aegis Capital; Merriman...
...shares will be sold with a five-year warrant to purchase a share. AtheroNova also added Merriman...
BioCentury | Nov 22, 2010
Finance

Avanir raises $88M after Nuedexta approval for involuntary laughing, crying

...BlackRock (1.9% at Sept. 30). Underwriters were Jefferies; Canaccord; Wedbush; Summer Street Research Partners; and Merriman...
BioCentury | Nov 22, 2010
Financial News

Avanir completes follow-on

...20 million Price: $4.40 Shares after offering: 114 million Underwriters: Jefferies; Canaccord; Wedbush; Summer Street; Merriman...
BioCentury | Nov 18, 2010
Financial News

Avanir raises $88M following Nuedexta approval

...per share in a follow-on underwritten by Jefferies; Canaccord; Wedbush; Summer Street Research Partners; and Merriman...
Items per page:
1 - 10 of 163